• Saledovil@sh.itjust.works
    link
    fedilink
    English
    arrow-up
    1
    ·
    1 day ago

    Two things wrong with this:

    1. There’s more than one pharmaceutical company. Providing a better cure than your competitors allows you to take their customers. Hence increasing your market share and your profit.
    2. People would be willing to pay more for the one time cure than for the long term therapy. And since the cure is so cheap to make, presumably cheaper than the traditional therapy, the cheap cure can be sold at an even greater profit than the traditional therapy.

    You need to remember that the global capitalist economy is not one team.